MedPath

Polypharmacy as a result of multiple chronic conditions of older people: rational therapy with the new FORTA classification?

Not Applicable
Recruiting
Conditions
eligible for the study are patients of a geriatric unit with numerous co-morbid conditions.
Registration Number
DRKS00000531
Lead Sponsor
Institut für klinische Pharmakologie MannheimUniversität Heidelberg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
400
Inclusion Criteria

informed consent given,
stable clinical condition,
no palliative condition

Exclusion Criteria

missing informed consent,
palliative clinical condition,
unstable clinical condition,
need of intensive care unit (ICU) treatment

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The FORTA classification encompasses four classes of drugs. Drugs with well documented evidence for the elderly constitute the classes A and B, drugs with limited evidence constitute the class C. Drug of the class D should be avoided in the elderly.<br><br>The aim of the study is the statistical measurement of the difference in the distribution of medication at discharge according to the four classes of FORTA between the two patient groups (clusters). <br><br>
Secondary Outcome Measures
NameTimeMethod
Statistically comparisone of the the two clusters regarding<br>Number of untreated disease<br>Number of diseases overtreated
© Copyright 2025. All Rights Reserved by MedPath